Clinical information
Diagnostic Utility:
This is the confirmatory detection of IgG antibodies against recombinant proteins (TpN47, TpN17, and TpN15) and a synthetic peptide (TmpA) of Treponema pallidum, and its determination is useful in:
- Confirmation of individuals with a chronic infection or past infection by Treponema pallidum.
- Transfusion of blood components.
- Transplantation of progenitor cells, solid organs, and tissues.
- Screening infectious diseases in egg and semen donors.
Method:
Immunochromatographic assay.
Reference Values
Possible results are: Reactive, Indeterminate, and Non-Reactive.
Diagnostic Algorithm:
Not applicable.
Turnaround Time:
Maximum of 15 working days.
Specimen information
Sample: Serum and/or plasma
Tube: 1-5 mL aliquots, plasma tubes with EDTA, potassium oxalate, sodium citrate, ACD, CP2D, CPD or CPDA-1 as anticoagulant and/or serum tubes with and without gel separator.
Minimum essential volume: 1 ml
Stability:
- At room temperature: ≤ 4 days
- In refrigeration 2-8 °C: ≤ 7 days
- Sample frozen at or below -20°C: 10 years
Transport instructions: Preferably at room temperature and/or refrigerated if they are whole blood tubes and frozen if they are serum and/or plasma aliquots.
Reason for rejection: Highly hemolyzed sample.
Administrative information
BST Code: 0134
Test Description: Treponema pallidum, IgG. Confirmation by Immunoblot.
Synonyms: Syphilis confirmation
Section: Transfusion Safety Laboratory
BST Rate: Check the updated rates here.
Profiles:
N/A.
References
- Inserts kits test FUJIREBIO INNO-LIA Syphilis Score.
Quality
BST holds ISO 9001, ISO 14001, and OSHAS 18001 quality certifications, as well as the European Excellence 500+ seal. BST is accredited by CAT, JACIE-FACT, FACT-NETCORD, and EFI, and complies with Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) guidelines.